PRESS RELEASE published on 04/18/2023 at 08:00, 3 years 3 months ago Biophytis Announces 2022 Financial Results and 2023 Perspectives
PRESS RELEASE published on 04/17/2023 at 23:00, 3 years 3 months ago Biophytis: Results of the Combined General Meeting on April 17, 2023
PRESS RELEASE published on 04/17/2023 at 23:00, 3 years 3 months ago Biophytis: Résultats de l’Assemblée Générale Mixte du 17 avril 2023
PRESS RELEASE published on 03/30/2023 at 23:00, 3 years 3 months ago Biophytis: L’Assemblée Générale mixte se tiendra en seconde convocation le 17 avril 2023
PRESS RELEASE published on 03/30/2023 at 23:00, 3 years 3 months ago Biophytis: The Combined General Meeting will be held on second call on April 17, 2023
PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 4 months ago Biophytis a présenté Sarconeos (BIO101) comme potentiel candidat médicament dans le traitement du COVID long après hospitalisation, lors du 13ème Congrès annuel International sur la Fragilité et la Sa
PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 4 months ago Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 4 months ago Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 4 months ago Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years 4 months ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
Published on 07/30/2026 at 00:50, 1 hour 3 minutes ago Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 1 hour 53 minutes ago American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 2 hours 52 minutes ago Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/29/2026 at 23:00, 2 hours 53 minutes ago NiobiumX Mining Inc. Commences Trading on the Canadian Securities Exchange Under the Symbol "NIOX", Completing Its Transition to a Niobium and Rare Earth Exploration Company Focused on Quebec's Saguenay Region
Published on 07/29/2026 at 21:45, 4 hours 7 minutes ago Piramal Pharma Limited Announces Results for Q1 FY27
Published on 07/29/2026 at 21:12, 4 hours 40 minutes ago Interim individual report for the period ending on 30.06.2026
Published on 07/29/2026 at 18:25, 7 hours 27 minutes ago International Fencing Federation prevails over Reuters in court - Court of Appeal prohibits false claims about the open letter to the IOC
Published on 07/29/2026 at 18:21, 7 hours 31 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/29/2026 at 18:07, 7 hours 45 minutes ago Quarterly Activities Report for the period ending 30 June 2026
Published on 07/29/2026 at 23:00, 2 hours 53 minutes ago BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Published on 07/29/2026 at 23:00, 2 hours 53 minutes ago Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Published on 07/29/2026 at 18:40, 7 hours 12 minutes ago Aéroports de Paris SA - Mise à disposition du rapport financier semestriel 2026
Published on 07/29/2026 at 18:40, 7 hours 12 minutes ago Aéroports de Paris SA - Availability of the 2026 financial interim report
Published on 07/29/2026 at 18:30, 7 hours 23 minutes ago Aéroports de Paris SA - Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) project
